US FDA warns repackers distributing pharmaceutical ingredients


Your substances

None


The U.S. Food and Drug Administration has issued warning letters to three repackers of active pharmaceutical ingredients (API), B&B Pharmaceuticals, Inc., Asclemed USA, Inc., doing business as Enovachem and Spectrum Laboratory Products, Inc., for significant violations of current good manufacturing practice (CGMP) requirements.

CONTINUE READING ON www.fda.gov

                   

Related News

Loading...